Wikidata entity: Q62024879
Quantities
| P2899 | minimum age | 18 |
| P1132 | number of participants | 72 |
| P6099 | clinical trial phase | ... | Q5452194 (phase I clinical trial) | phase I clinical trial |
| P582 | end time | ... | 2022-10-31 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P921 | main subject | ... | Q187255 (rheumatoid arthritis) | rheumatoid arthritis |
| P921 | main subject | ... | Q1477 (ulcerative colitis) | ulcerative colitis |
| P921 | main subject | ... | Q707816 (giant cell arteritis) | giant cell arteritis |
| P921 | main subject | ... | Q19000413 (non small cell lung cancer recurrent) | non small cell lung cancer recurrent |
| P1050 | medical condition | ... | Q8277 (multiple sclerosis) | multiple sclerosis |
| P1050 | medical condition | ... | Q140067 (sclerosis) | sclerosis |
| P1050 | medical condition | ... | Q170990 (arthritis) | arthritis |
| P1050 | medical condition | ... | Q1752891 (polymyalgia rheumatica) | polymyalgia rheumatica |
| P1050 | medical condition | ... | Q179945 (psoriasis) | psoriasis |
| P1050 | medical condition | ... | Q2453464 (colitis) | colitis |
| P4844 | research intervention | ... | Q7041828 (nivolumab) | nivolumab |
| P6153 | research site | ... | Q126412 (Massachusetts General Hospital) | Massachusetts General Hospital |
| P6153 | research site | ... | Q30279912 (Duke University Medical Center) | Duke University Medical Center |
| P8005 | research subject recruitment status | ... | Q76649708 (recruiting) | recruiting |
| P580 | start time | ... | 2018-10-31 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | Safety, Activity, and Pharmacology of Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease | ??? |
| P3098 | ClinicalTrials.gov ID | NCT03656627 |
Why not click here or view trends?
log id: 4223170